Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Basel Medical (BMGL) Cash & Current Investments (2023 - 2025)

Historic Cash & Current Investments for Basel Medical (BMGL) over the last 3 years, with Q2 2025 value amounting to $2.3 million.

  • Basel Medical's Cash & Current Investments rose 5870.66% to $2.3 million in Q2 2025 from the same period last year, while for Jun 2025 it was $2.3 million, marking a year-over-year increase of 5870.66%. This contributed to the annual value of $2.2 million for FY2025, which is 5592.15% up from last year.
  • As of Q2 2025, Basel Medical's Cash & Current Investments stood at $2.3 million, which was up 5870.66% from $1.5 million recorded in Q4 2024.
  • In the past 5 years, Basel Medical's Cash & Current Investments ranged from a high of $2.3 million in Q2 2025 and a low of $901754.5 during Q4 2023
  • Over the past 3 years, Basel Medical's median Cash & Current Investments value was $1.5 million (recorded in 2024), while the average stood at $1.5 million.
  • Per our database at Business Quant, Basel Medical's Cash & Current Investments soared by 6265.58% in 2024 and then soared by 5870.66% in 2025.
  • Quarter analysis of 3 years shows Basel Medical's Cash & Current Investments stood at $901754.5 in 2023, then surged by 62.66% to $1.5 million in 2024, then soared by 56.04% to $2.3 million in 2025.
  • Its last three reported values are $2.3 million in Q2 2025, $1.5 million for Q4 2024, and $1.4 million during Q2 2024.